Tag Archives: J&J COVID-19 vaccine protects monkeys in a single dose

CHICAGO: Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose. When exposed to the virus, six out of six animals who got the candidate vaccine were completely protected from lung disease and five …

Read More »